Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unión Europea - español - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - irbesartán, hidroclorotiazida - hipertensión - agentes que actúan sobre el sistema renina-angiotensina - el tratamiento de la hipertensión esencial. esta combinación de dosis fija está indicado en pacientes adultos cuya presión arterial no está controlada adecuadamente con irbesartán o hidroclorotiazida solos (véase la sección 5.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

chemical advances corp. peru s.a.c. - clorhidrato de clindamicina; - capsula - por capsula; clorhidrato de clindamicina 348.600000 mg; - clindamicina

Argentina - español - SANI (Asociación de Cooperativas Argentinas)

labyes s. a. - imidacloprid; piriproxifeno; excipientes c.s.p. - imidacloprid 11,00 g; piriproxifeno 3,00 g; excipientes c.s.p. 100 ml - felinos

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

protech biosystems pvt ltd. [in] india - cefepima clorhidrato usp 1,740 mg equivalente a cefepima base 1,000 mg - polvo esteril para inyecciÓn - cada frasco vial de 100 ml contiene: cefepima clorhidrato usp 1,740 mg equivalente a cefepima base 1,000 mg (buferizado con l-arginina)

Argentina - español - SANI (Asociación de Cooperativas Argentinas)

labyes s. a. - fipronil; permetrina; butóxido de piperonilo; piriproxifeno; excipientes c.s.p. - fipronil 10,0 g; permetrina 40,0 g; butóxido de piperonilo 3,0 g; piriproxifeno 10,0 g; excipientes c.s.p. 100 ml - caninos

Argentina - español - SANI (Asociación de Cooperativas Argentinas)

labyes s. a. - imidacloprid; permetrina; butóxido de piperonilo; piriproxifeno; excipientes c.s.p. - imidacloprid 0,25 g; permetrina 2,00 g; butóxido de piperonilo 0,30 g; piriproxifeno 0,25 g; excipientes c.s.p. 100 ml - caninos